Front Row Advisors’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-564
| Closed | -$60K | – | 738 |
|
|
2024
Q2 | $60K | Hold |
564
| – | – | 0.02% | 249 |
|
|
2024
Q1 | $54.6K | Buy |
+564
| New | +$54.6K | 0.02% | 250 |
|
|
2023
Q4 | – | Sell |
-448
| Closed | -$45.6K | – | 705 |
|
|
2023
Q3 | $45.6K | Buy |
448
+29
| +7% | +$2.95K | 0.02% | 247 |
|
|
2023
Q2 | $42K | Hold |
419
| – | – | 0.02% | 259 |
|
|
2023
Q1 | $39K | Sell |
419
-3
| -0.7% | -$279 | 0.02% | 270 |
|
|
2022
Q4 | $38K | Sell |
422
-76
| -15% | -$6.84K | 0.02% | 270 |
|
|
2022
Q3 | $38K | Buy |
498
+138
| +38% | +$10.5K | 0.02% | 268 |
|
|
2022
Q2 | $30K | Sell |
360
-12
| -3% | -$1K | 0.01% | 302 |
|
|
2022
Q1 | $33K | Sell |
372
-4
| -1% | -$355 | 0.01% | 312 |
|
|
2021
Q4 | $33K | Buy |
376
+25
| +7% | +$2.19K | 0.01% | 321 |
|
|
2021
Q3 | $29K | Hold |
351
| – | – | 0.01% | 339 |
|
|
2021
Q2 | $33K | Sell |
351
-78
| -18% | -$7.33K | 0.01% | 322 |
|
|
2021
Q1 | $37K | Sell |
429
-1
| -0.2% | -$86 | 0.02% | 293 |
|
|
2020
Q4 | $41K | Hold |
430
| – | – | 0.02% | 277 |
|
|
2020
Q3 | $39K | Sell |
430
-179
| -29% | -$16.2K | 0.02% | 275 |
|
|
2020
Q2 | $53K | Buy |
609
+95
| +18% | +$8.27K | 0.03% | 217 |
|
|
2020
Q1 | $44K | Buy |
514
+103
| +25% | +$8.82K | 0.03% | 230 |
|
|
2019
Q4 | $39K | Sell |
411
-28
| -6% | -$2.66K | 0.03% | 225 |
|
|
2019
Q3 | $38K | Sell |
439
-38
| -8% | -$3.29K | 0.03% | 224 |
|
|
2019
Q2 | $44K | Sell |
477
-82
| -15% | -$7.56K | 0.03% | 216 |
|
|
2019
Q1 | $48K | Buy |
559
+10
| +2% | +$859 | 0.04% | 210 |
|
|
2018
Q4 | $42K | Buy |
549
+261
| +91% | +$20K | 0.04% | 212 |
|
|
2018
Q3 | $22 | Buy |
288
+34
| +13% | +$3 | 0.02% | 297 |
|
|
2018
Q2 | $19 | Buy |
254
+31
| +14% | +$2 | 0.01% | 342 |
|
|
2018
Q1 | $16K | Hold |
223
| – | – | 0.01% | 360 |
|
|
2017
Q4 | $17K | Buy |
+223
| New | +$17K | 0.01% | 356 |
|